Gershtein, E S <br/><br/>
Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.  [electronic resource] 

 -  Bulletin of experimental biology and medicine  Jul 2001 
 - 670-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-4888 
<br/><br/><label>Standard No.: </label>10.1023/a:1012532412896  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Male<br/>Melanoma--enzymology<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--metabolism<br/>Serine Proteinase Inhibitors--metabolism<br/>Skin Neoplasms--enzymology<br/>Statistics as Topic<br/>Tissue Plasminogen Activator--metabolism<br/>Urokinase-Type Plasminogen Activator--metabolism